Separate terms with OR to return results that match either term.
 
Clear All
10,000 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status (Ascending)
63323-0750-27 63323-0750 Oxaliplatin Oxaliplatin 5.0 mg/mL Chemotherapy Alkylating Agent Platinum Compound Intravenous June 11, 2010 Jan. 17, 2019 In Use
63323-0762-10 63323-0762 Topotecan Hydrochloride Topotecan Hydrochloride 4.0 mg/4mL Chemotherapy Topoisomerase I Inhibitor Camptothecin Analogs Intravenous Nov. 30, 2010 In Use
63323-0762-17 63323-0762 Topotecan Hydrochloride Topotecan Hydrochloride 4.0 mg/4mL Chemotherapy Topoisomerase I Inhibitor Camptothecin Analogs Intravenous Nov. 30, 2010 Dec. 26, 2018 In Use
63323-0762-55 63323-0762 Topotecan Hydrochloride Topotecan Hydrochloride 4.0 mg/4mL Chemotherapy Topoisomerase I Inhibitor Camptothecin Analogs Intravenous Nov. 30, 2010 March 18, 2016 In Use
63323-0762-57 63323-0762 Topotecan Hydrochloride Topotecan Hydrochloride 4.0 mg/4mL Chemotherapy Topoisomerase I Inhibitor Camptothecin Analogs Intravenous Nov. 30, 2010 March 18, 2016 In Use
63323-0762-94 63323-0762 Topotecan Hydrochloride Topotecan Hydrochloride 4.0 mg/4mL Chemotherapy Topoisomerase I Inhibitor Camptothecin Analogs Intravenous Nov. 30, 2010 In Use
63323-0763-05 63323-0763 Paclitaxel Paclitaxel 6.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous March 20, 2009 In Use
63323-0763-06 63323-0763 Paclitaxel Paclitaxel 6.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Aug. 15, 2014 Jan. 31, 2017 In Use
63323-0763-16 63323-0763 Paclitaxel Paclitaxel 6.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous March 20, 2009 In Use
63323-0763-17 63323-0763 Paclitaxel Paclitaxel 6.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Aug. 15, 2014 Dec. 31, 2016 In Use
63323-0763-50 63323-0763 Paclitaxel Paclitaxel 6.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous March 20, 2009 In Use
63323-0763-52 63323-0763 Paclitaxel Paclitaxel 6.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Aug. 15, 2014 Feb. 28, 2017 In Use
63539-0026-01 63539-0026 Axitinib Inlyta 1.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor VEGFR Oral Jan. 27, 2012 In Use
64679-0067-02 64679-0067 decitabine Decitabine 50.0 mg/20mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Dec. 14, 2020 In Use
67457-0436-50 67457-0436 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Feb. 27, 2014 In Use
67457-0442-20 67457-0442 Oxaliplatin Oxaliplatin 5.0 mg/mL Chemotherapy Alkylating Agent Platinum Compound Intravenous May 16, 2014 In Use
67457-0469-10 67457-0469 Oxaliplatin Oxaliplatin 5.0 mg/mL Chemotherapy Alkylating Agent Platinum Compound Intravenous Aug. 25, 2014 In Use
67457-0533-16 67457-0533 DOCETAXEL ANHYDROUS Docetaxel 10.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Sept. 5, 2018 In Use
67457-0616-10 67457-0616 GEMCITABINE HYDROCHLORIDE Gemcitabine 200.0 mg/5.26mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Jan. 3, 2018 In Use
67457-0617-30 67457-0617 GEMCITABINE HYDROCHLORIDE Gemcitabine 1.0 g/26.3mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Dec. 18, 2017 In Use
67457-0618-10 67457-0618 GEMCITABINE HYDROCHLORIDE Gemcitabine 2.0 g/52.6mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Dec. 18, 2017 In Use
67457-0781-08 67457-0781 Docetaxel Docetaxel 20.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous June 18, 2019 In Use
67979-0001-01 67979-0001 Valrubicin Valstar 40.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravesical Oct. 1, 1998 In Use
67979-0001-02 67979-0001 Valrubicin Valstar 40.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravesical Oct. 1, 1998 Oct. 17, 2017 In Use
68001-0265-22 68001-0265 Etoposide Etoposide 20.0 mg/mL Chemotherapy Plant Alkaloid Epipodophyllotoxins Intravenous Nov. 14, 2013 In Use
68001-0265-23 68001-0265 Etoposide Etoposide 20.0 mg/mL Chemotherapy Plant Alkaloid Epipodophyllotoxins Intravenous Nov. 14, 2013 In Use
68001-0265-24 68001-0265 Etoposide Etoposide 20.0 mg/mL Chemotherapy Plant Alkaloid Epipodophyllotoxins Intravenous Nov. 14, 2013 In Use
68001-0265-25 68001-0265 Etoposide Etoposide 20.0 mg/mL Chemotherapy Plant Alkaloid Epipodophyllotoxins Intravenous Nov. 14, 2013 In Use
68001-0265-26 68001-0265 Etoposide Etoposide 20.0 mg/mL Chemotherapy Plant Alkaloid Epipodophyllotoxins Intravenous Nov. 14, 2013 In Use
68001-0265-27 68001-0265 Etoposide Etoposide 20.0 mg/mL Chemotherapy Plant Alkaloid Epipodophyllotoxins Intravenous Nov. 14, 2013 In Use
69097-0372-47 69097-0372 Docetaxel Anhydrous Docetaxel Anhydrous 160.0 mg/16mL Chemotherapy Antimitotic Agent Taxane Intravenous Aug. 24, 2018 Aug. 26, 2020 In Use
70121-1218-01 70121-1218 Doxorubicin Doxorubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Feb. 17, 2017 In Use
70121-1218-07 70121-1218 Doxorubicin Doxorubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Feb. 17, 2017 In Use
70121-1567-01 70121-1567 Bleomycin Bleomycin 15000.0 [iU]/1 Chemotherapy Antitumor Antibiotic Carboxylic Acids and Amino Acids/Peptides Intra-Arterial, Intramuscular, Intravenous June 20, 2016 In Use
70700-0174-22 70700-0174 Docetaxel Docetaxel 10.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Oct. 25, 2021 In Use
70700-0175-22 70700-0175 Docetaxel Docetaxel 10.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Oct. 25, 2021 In Use
70700-0176-22 70700-0176 Docetaxel Docetaxel 10.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Oct. 25, 2021 In Use
71288-0109-20 71288-0109 cytarabine Cytarabine 2.0 g/20mL Chemotherapy Antimetabolite Pyrimidine Analog Intrathecal, Intravenous, Subcutaneous July 17, 2018 In Use
71288-0115-30 71288-0115 Azacitidine Azacitidine 100.0 mg/30mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous, Subcutaneous Nov. 2, 2020 In Use
72485-0211-02 72485-0211 Irinotecan Hydrochloride Irinotecan Hydrochloride 20.0 mg/mL Chemotherapy Topoisomerase I Inhibitor Camptothecin Analogs Intravenous April 1, 2019 In Use
72485-0212-05 72485-0212 Irinotecan Hydrochloride Irinotecan Hydrochloride 20.0 mg/mL Chemotherapy Topoisomerase I Inhibitor Camptothecin Analogs Intravenous April 1, 2019 In Use
72694-0515-01 72694-0515 Calaspargase Pegol Asparlas 750.0 U/mL Chemotherapy Miscellaneous Agent Enzyme Intravenous Sept. 27, 2019 In Use
00085-4347-01 00085-4347 Peginterferon alfa-2b Sylatron Immunotherapy Cytokine Interferon Aug. 30, 2014 Oct. 18, 2020 In Use
00085-4348-01 00085-4348 Peginterferon alfa-2b Sylatron Immunotherapy Cytokine Interferon March 29, 2011 Oct. 18, 2020 In Use
00085-4349-01 00085-4349 Peginterferon alfa-2b Sylatron Immunotherapy Cytokine Interferon March 29, 2011 Oct. 18, 2020 In Use
57894-0502-05 57894-0502 Daratumumab Darzalex 100.0 mg/5mL Immunotherapy Monoclonal Antibody CD38 Intravenous Nov. 16, 2015 In Use
57894-0502-20 57894-0502 Daratumumab Darzalex 100.0 mg/5mL Immunotherapy Monoclonal Antibody CD38 Intravenous Nov. 16, 2015 In Use
00069-4031-01 00069-4031 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous March 5, 2013 April 30, 2021 In Use
00069-4033-01 00069-4033 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous March 5, 2013 Nov. 30, 2020 In Use
00078-0438-15 00078-0438 Imatinib Mesylate Gleevec 400.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral May 15, 2001 May 31, 2017 In Use

Found 10,000 results in 5 milliseconds — Export these results